[go: up one dir, main page]

CA2697189A1 - Schema posologique - Google Patents

Schema posologique Download PDF

Info

Publication number
CA2697189A1
CA2697189A1 CA2697189A CA2697189A CA2697189A1 CA 2697189 A1 CA2697189 A1 CA 2697189A1 CA 2697189 A CA2697189 A CA 2697189A CA 2697189 A CA2697189 A CA 2697189A CA 2697189 A1 CA2697189 A1 CA 2697189A1
Authority
CA
Canada
Prior art keywords
active agent
daily dose
patient
dosage form
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2697189A
Other languages
English (en)
Inventor
Gary Liversidge
Scott Jenkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perrigo Pharma International DAC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2697189A1 publication Critical patent/CA2697189A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2697189A 2007-09-12 2008-09-12 Schema posologique Abandoned CA2697189A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97188207P 2007-09-12 2007-09-12
US60/971,882 2007-09-12
PCT/US2008/076189 WO2009036287A1 (fr) 2007-09-12 2008-09-12 Schéma posologique

Publications (1)

Publication Number Publication Date
CA2697189A1 true CA2697189A1 (fr) 2009-03-19

Family

ID=40452511

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2697189A Abandoned CA2697189A1 (fr) 2007-09-12 2008-09-12 Schema posologique

Country Status (4)

Country Link
EP (1) EP2197448A4 (fr)
JP (1) JP2010539184A (fr)
CA (1) CA2697189A1 (fr)
WO (1) WO2009036287A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0979635A2 (fr) 1998-08-12 2000-02-16 Origin Medsystems, Inc. Dissecteur de tissu
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
WO2001032148A1 (fr) 1999-10-29 2001-05-10 Euro-Celtique, S.A. Formulations d'hydrocodone a liberation lente
CN101317825A (zh) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
US6558313B1 (en) 2000-11-17 2003-05-06 Embro Corporation Vein harvesting system and method
US9149472B2 (en) 2004-08-31 2015-10-06 Jack William Schultz Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
US9770230B2 (en) 2006-06-01 2017-09-26 Maquet Cardiovascular Llc Endoscopic vessel harvesting system components
US10322120B2 (en) 2012-07-31 2019-06-18 Persion Pharmaceuticals Llc Treating pain in patients with hepatic impairment
US20140161879A1 (en) * 2012-07-31 2014-06-12 Zogenix, Inc. Treating pain in patients with hepatic impairment
AR094117A1 (es) * 2012-12-20 2015-07-08 Sanofi Aventis Deutschland Conjunto de envasado para dispositivos de administracion de farmacos
WO2015065497A1 (fr) * 2013-11-04 2015-05-07 Schultz Jack William Traitement de troubles et problèmes cognitifs, émotionnels et mentaux

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US7674776B2 (en) * 1999-06-14 2010-03-09 Vivus, Inc. Combination therapy for effecting weight loss and treating obesity
CN100408029C (zh) * 2001-09-28 2008-08-06 麦克内尔-Ppc股份有限公司 有镶嵌部分的组合剂型
GB0201367D0 (en) * 2002-01-22 2002-03-13 Ml Lab Plc Composition
US20050158382A1 (en) * 2003-09-26 2005-07-21 Evangeline Cruz Controlled release formulations of opioid and nonopioid analgesics
US7188738B2 (en) * 2004-03-18 2007-03-13 Customer Advantage Llc Medication minder
EP1771158A4 (fr) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Comprimé pour distribution par impulsion
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems

Also Published As

Publication number Publication date
EP2197448A1 (fr) 2010-06-23
EP2197448A4 (fr) 2010-11-17
JP2010539184A (ja) 2010-12-16
WO2009036287A1 (fr) 2009-03-19

Similar Documents

Publication Publication Date Title
US20090149479A1 (en) Dosing regimen
CA2697189A1 (fr) Schema posologique
CA2668884C (fr) Formulations pharmaceutiques en couches
JP2011501736A (ja) 経口投与用配合剤型医薬パッケージング
CN107412173A (zh) 抗篡改固体口服剂型
EP2061448B1 (fr) Formulation à libération prolongée de naltréxone
JP2009511191A (ja) 経口投与剤組合せ型医薬パッケージ法
WO2005082143A1 (fr) Compositions et methodes de regulation du sommeil
KR20120120960A (ko) 비만 및 비만 관련 질환 치료용 조성물 및 비만 및 비만 관련 질환의 치료방법
KR20190086712A (ko) 리도카인-비유효 병태 및 저칼륨혈성 병태의 치료를 위한 요법
CA2516327A1 (fr) Systeme therapeutique a base d'amoxicilline et d'acide clavulanique
JP4553552B2 (ja) 生体リズム応用キット
US20100136106A1 (en) Modified Release Famciclovir Compositions
US20090297597A1 (en) Modified Release Ticlopidine Compositions
EP1901718A1 (fr) Compositions de ticlopidine à diffusion modifiée
WO2019055859A1 (fr) Traitement du syndrome métabolique par des un stimulateur de sgc
RU2319476C2 (ru) Устройство лекарственное
WO2023031779A1 (fr) Compositions, kits et procédés pour fournir des effets synergiques et/ou additifs à partir d'ingrédients composés pour la prévention, le traitement et la gestion de la nausée et des vomissements
HK40014066A (en) Therapies for the treatment of lidocaine-ineffective and hypokalemic conditions
HK40016624A (en) Novel dosage form
WO2021173584A1 (fr) Ensemble de gestion de la douleur multimédicamenteux
HK1051495A1 (en) Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication
HRP20100376T1 (hr) Uporaba pipamperona i antagonista d2-receptora ili antagonista serotonin/dopamina za liječenje psihotičnih poremećaja
HK1121693A (en) Pharmaceutical packaging of an oral dosage combination
MX2008004895A (en) Pharmaceutical packaging of an oral dosage combination

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140912